Acute liver failure (ALF) is an uncommon medical emergency whose rapid progression and high mortality demand early diagnosis and expert management, including immediate transfer of any potential case to facilities for intensive care and orthotopic liver transplantation (OLT). All patients with ALF must be screened aggressively for acetaminophen toxicity (history, serum levels, “hyperacute” presentation with renal failure), for other drugs, and viral hepatitis; rare causes of ALF should also be considered. After an acetaminophen overdose, N-acetylcysteine must be given as early as possible, preferably in the emergency room, but any patient with ALF should promptly receive N-acetylcysteine if there is suspicion of acetaminophen toxicity irrespective of the time of ingestion. Supportive care for all patients with ALF includes adequate enteral nutrition, aggressive screening and treatment of infection, prophylactic broad-spectrum antibiotics, and antifungal agents. Sedation with propofol is given for severe agitation or mechanical ventilation. With advanced coma grades, intensive care is needed with hemodynamic monitoring, ventilatory support, continuous renal replacement for renal failure, and intracranial pressure monitoring. Intracranial hypertension is treated with mannitol and/or acute short-term hyperventilation, but if the patient is refractory to treatment, mild-moderate hypothermia is achieved by a cooling blanket that is continued throughout OLT. Barbiturate coma is only used in refractory cases as the last treatment modality. Seizures are aggressively treated with phenytoin, with additional diazepam as needed. Candidacy and activation for OLT should be completed as early as possible in the course of ALF, especially in “hyperacute” cases such as acetaminophen toxicity. The final decision to proceed with OLT is made when a donor organ becomes available. King’s College Hospital criteria for OLT are still the best prognostic assessment for fatal outcome in ALF, but the criteria fail to identify some patients who will die.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
References and Recommended Reading
Lee WM: Acute liver failure. Clin Perspectives Gastroenterol 2001, 101–110.
Sass DA, Shakil AO: Fulminant hepatic failure. Gastroenterol Clin North Am 2003, 32: 1195–1211.
Ostapowicz G, Fontana RJ, Schiodt FV, et al.: Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002, 137: 947–954. First large prospective, multicentre study of ALF in the USA with 308 patients showing the major etiologies of ALF and the survival both, spontaneous and with transplantation.
Schiodt FV, Davern TJ, Shakil AO, et al.: Vital hepatitisrelated acute liver failure. Am J Gastroenterol 2003, 98: 448–453.
Lee WM: Drug-induced hepatotoxicity. N Eng J Med 2003, 349: 474–485.
Stedman C: Herbal hepatotoxicity. Semin Liver Dis 2002, 22: 195–206.
Estes JD, Stolpman D, Olyaei A, et al.: High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg 2003, 138: 852–858.
Russo MW, Glanako JA, Shrestha R, et al.: Liver transplantation for acute liver failure from drug induced liver injury in the United States. AU: Please supply journal title 2004, 10: 1018–1023.
Sharma S, Mosunjac M: Herpes simplex hepatitis in adults. Gastroenterol 2004, 38: 697–704.
Roberts EA, Schilsky ML: A practice guideline on Wilson disease. Hepatology 2003, 37: 1475–1492.
Brok J, Buckley N, Gluud C: Interventions for paracetamol (acetaminophen) overdoses. Cochrane Database Syst Rev 2002, 3: CD003328.
Sato RL, Wong JJ, Sumida SM, et al.: Efficacy of superactivated charcoal administered late (3 hours) after acetaminophen overdose. Am J Emerg Med 2003, 21: 189–191.
Czaja AJ, Freese DK: Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002, 36: 479–497.
Ch’ng CL, Morgan M, Hainsworth I, Kingham JG: Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002, 51: 867–880.
Rahman TM, Wendon J: Severe hepatic dysfunction in pregnancy. QJM 2002, 95: 343–357.
Peters DJ, Greene WH, Ruggiero F, McGarrity TJ: Herpes simplex-induced fulminant hepatitis in adults: a call for empiric therapy. Dig Dis Sci 2000, 45: 2399–2404.
Enhalbert F, Rapior S, Nouguier-Soule J, et al.: Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol 2002, 40: 715–757.
Lee WC, Wu MJ, Cheng CH, et al.: Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. Am J Kidney Dis 2001, 38: 1074–1081.
Walsh TS, Wigmore SJ, Hopton P, et al.: Energy expenditure in acetaminophen-induced fulminant hepatic failure. Crit Care Med 2000, 28: 649–654.
Rolando N, Wade J, Davalos M, et al.: The systemic inflammatory response syndrome in acute liver failure. Hepatology 2002, 32: 734–739.
Vaquero J, Polson J, Chung C, et al.: Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 2003, 125: 755–764. Large study of 227 patients with ALF with early coma grade. Patients were followed and infection and the systemic inflammatory response were identified as important predictors of worsening encephalopathy, especially in acetaminophen ALF.
Jalan R, Williams R: The inflammatory basis of intracranial hypertension in acute liver failure. J Hepatol 2001, 34: 940–942.
Rolando N, Wade JJ, Stangou A, et al.: Prospective study comparing the efficacy of prophylactic parenteral antimcrobials, with or without enteral decontamination, in patients with acute liver failure. Liver Transpl Surg 1996, 2: 8–13.
Fisher NC, Cooper MA, Hastings JGM, et al.: Fungal colonisation and fluconazole therapy in acute liver disease. Liver 1998, 18: 320–325.
Shami VM, Caldwell SH, Hespenheide EE, et al.: Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 2003, 9: 138–143.
Blei AT, Larsen FS: Pathophysiology of cerebral edema in fulminant hepatic failure. J Hepatol 1999, 31: 771–776.
Larsen FS, Wendon J: Brain edema in liver failure: basic physiologic principles and management. Liver Transpl 2002, 8: 983–989.
Vaquero J, Chung C, Cahill ME, Blei AT: Pathogenesis of hepatic encephalopathy in acute liver failure. Semin Dis 2003, 23: 259–269.
Jalan R, Olde Damink SWM, Deutz NEP, et al.: Restoration of cerebral blood flow autoregulation and reactivity to carbon dioxide in acute liver failure by moderate hypothermia. Hepatology 2001, 34: 50–54.
Blei A: Medical therapy of brain edema in fulminant hepatic failure. Hepatology 2000, 32: 666–669.
Rose C, Michalak A, Pannunzio M, et al.: Mild hypothermia delays onset of coma and prevents brain edema and extracellular brain glutamate accumulation in rats with acute liver failure. Hepatology 2000, 31: 872–877.
Clemmesen JO, Larsen FS, Kondrup J, et al.: Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999, 29: 648–653.
Alba L, Hay JE, Angulo P, Lee WM: Lactulose therapy in acute liver failure. J Hepatol 2002, 36: 33A.
Strauss G, Hansen BA, Knudsen GM, Larsen FS: Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure. J Hepatol 1998, 28: 199–203.
Ede RJ, Gimson AES, Bihari D, Williams R: Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol 1986, 2: 43–51.
Canalese J, Gimson AES, Davis C, et al.: Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut 1982, 23: 625–629.
Butterworth RF: Mild hypothermia prevents cerebral edema in acute liver failure. J Hepatobiliary Pancreat Surg 2001, 8: 16–19.
Jalan R, Damink SWMO, Duetz NEP, Lee A, Hayes PC: Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 1999, 354: 1164–1168.
Jalan R, Olde Damink SWM: Hypothermia for the management of intracranial hypertension in acute liver failure. Curr Opin Crit Care 2001, 7: 257–262.
Jalan R, Olde Damink SWM, Duetz NEP, et al.: Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation 2003, 75: 2034–2039. Extension of previous work on hypothermia to treat intracranial hypertension. This study shows the efficacy and safety of moderate hypothermia to prevent increases in intracranial pressure during liver transplantation.
Murphy N, Auzinger G, Bernel W, Wendon J: The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004, 39: 464–470.
Larsen FS, Hansen BA, Blei AT: Intensive care management of patients with acute liver failure with emphasis on systemic hemodynamic instability and cerebral edema: a critical appraisal of pathophysiology. Can J Gastroenterol 2000, 14: 105D-111D.
Davenport A: s there a role for continuous renal replacement therapies in patients with liver and renal failure? Kidney Int 1999, 72: S62-S66.
Shawcross DL, Davies NA, Mookerjee RP, et al.: Worsening of cerebral hyperemia by the administration of Terlipressin in acute liver failure with severe encephalopathy. Hepatology 2004, 39: 471–475.
Wijdicks EFM, Nyberg SL: Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc 2002, 34: 1220–1222.
Ellis AJ, Wendon JA, Williams R: Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology 2000, 32: 536–541.
Bhatia V, Batra Y, Acharya SK: Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure - a controlled clinical trial. Hepatology 2004, 41: 89–96.
Nyberg SL, Matsushita T, Gores G, et al.: The role of cellbased bioartificial liver therapy in the treatment of fulminant hepatic failure. Graft 2002, 5: 374–382.
Jalan R, Sen S, Williams R: Prospects for extracorporeal liver support. Gut 2004, 53: 890–898.
Demetriou AA, Brown RS, Busuttil RW, et al.: Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004, 239: 660–670.
Roberts MS, Angus DC, Bryce CL, et al.: Survival after liver transplantation in the United States: a diseasespecific analysis of the UNOS database. Liver Transpl 2004, 10: 886–897.
Bernal W, Donaldson N, Wyncoll D, Wendon J: Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 2002, 359: 558–563.
Brandsater B, Hockerstedt K, Friman S, et al.: Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation —12 years experience in the Nordic Countries. Liver Transpl 2002, 8: 1055–1062.
O’Grady JG, Alexander GJM, Hayllar KM, Williams R: Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989, 97: 439–45.
Riordan SM, Williams R: Use and validation of selection criteria for liver transplantation in acute liver failure. Liver Transpl 2000, 6: 170–173. Discussion and comparison of the different prognostic criteria for proceeding with liver transplantation in ALF.
Bailey B, Amre DK, Gaudreault P: Fulminant hepatic failure secondary to acetaminophen poisoning a systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med 2003, 31: 299–305.
Shakil AO, Kramer D, Mazariegos GV, et al.: Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000, 6: 163–169.
Rezende G, Roque-Afonso AM, Samuel D, et al.: Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology 2003, 38: 613–618.
About this article
Cite this article
Hay, J.E. Acute liver failure. Curr Treat Options Gastro 7, 459–468 (2004). https://doi.org/10.1007/s11938-004-0005-5
- Cerebral Edema
- Orthotopic Liver Trans
- Cerebral Perfusion Pressure
- Acute Liver Failure
- Fulminant Hepatic Failure